BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Cohen JI, Iwatsuki K, Ko YH, Kimura H, Manoli I, Ohshima K, Pittaluga S, Quintanilla-Martinez L, Jaffe ES. Epstein-Barr virus NK and T cell lymphoproliferative disease: report of a 2018 international meeting. Leuk Lymphoma 2020;61:808-19. [PMID: 31833428 DOI: 10.1080/10428194.2019.1699080] [Cited by in Crossref: 17] [Cited by in F6Publishing: 17] [Article Influence: 5.7] [Reference Citation Analysis]
Number Citing Articles
1 Qiu L, Si J, Kang J, Chen Z, Nuermaimaiti R, Qian Z, Li L, Zhou S, You MJ, Zhang H, Tian C. A retrospective analysis of EBV-DNA status with the prognosis of lymphoma. J Cell Mol Med 2022. [PMID: 36065965 DOI: 10.1111/jcmm.17543] [Reference Citation Analysis]
2 Alaggio R, Amador C, Anagnostopoulos I, Attygalle AD, Araujo IBO, Berti E, Bhagat G, Borges AM, Boyer D, Calaminici M, Chadburn A, Chan JKC, Cheuk W, Chng WJ, Choi JK, Chuang SS, Coupland SE, Czader M, Dave SS, de Jong D, Du MQ, Elenitoba-Johnson KS, Ferry J, Geyer J, Gratzinger D, Guitart J, Gujral S, Harris M, Harrison CJ, Hartmann S, Hochhaus A, Jansen PM, Karube K, Kempf W, Khoury J, Kimura H, Klapper W, Kovach AE, Kumar S, Lazar AJ, Lazzi S, Leoncini L, Leung N, Leventaki V, Li XQ, Lim MS, Liu WP, Louissaint A Jr, Marcogliese A, Medeiros LJ, Michal M, Miranda RN, Mitteldorf C, Montes-Moreno S, Morice W, Nardi V, Naresh KN, Natkunam Y, Ng SB, Oschlies I, Ott G, Parrens M, Pulitzer M, Rajkumar SV, Rawstron AC, Rech K, Rosenwald A, Said J, Sarkozy C, Sayed S, Saygin C, Schuh A, Sewell W, Siebert R, Sohani AR, Tooze R, Traverse-Glehen A, Vega F, Vergier B, Wechalekar AD, Wood B, Xerri L, Xiao W. The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Lymphoid Neoplasms. Leukemia 2022. [PMID: 35732829 DOI: 10.1038/s41375-022-01620-2] [Cited by in Crossref: 28] [Cited by in F6Publishing: 12] [Article Influence: 28.0] [Reference Citation Analysis]
3 Xiong X, Yu D, Gao Q, Zhang Y, Yin Q, Chen X, Xiao H, Tong R. Association between CYP2B6 c.516G >T variant and acute leukaemia: A protocol for systematic review and meta-analysis. Medicine (Baltimore) 2021;100:e26740. [PMID: 34397877 DOI: 10.1097/MD.0000000000026740] [Reference Citation Analysis]
4 Kimura H, Okuno Y, Sato Y, Watanabe T, Murata T. Deletion of Viral microRNAs in the Oncogenesis of Epstein-Barr Virus-Associated Lymphoma. Front Microbiol 2021;12:667968. [PMID: 34305835 DOI: 10.3389/fmicb.2021.667968] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
5 El-Mallawany NK, Curry CV, Allen CE. Haemophagocytic lymphohistiocytosis and Epstein-Barr virus: a complex relationship with diverse origins, expression and outcomes. Br J Haematol 2021. [PMID: 34169507 DOI: 10.1111/bjh.17638] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
6 Wang X, Liang Y, Yang Y, Li W, Wang G, Wang S, Li Y, Zhang M. Hydroa vacciniforme-like lymphoproliferative disorder: A clinicopathological, immunohistochemical, and prognostic study of 24 cases in China. J Dermatol 2021;48:1315-26. [PMID: 33982815 DOI: 10.1111/1346-8138.15944] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Oh SJ, Lee J, Park JH, Lee JH, Cho J, Ko YH, Lee D. Hydroa Vacciniforme-Like Lymphoproliferative Disorder in Korea: Prognostic Implication of Clinical Signs and Whole Blood Epstein-Barr Virus DNA. Ann Dermatol 2021;33:222-7. [PMID: 34079181 DOI: 10.5021/ad.2021.33.3.222] [Reference Citation Analysis]
8 Ko YH. EBV-Associated Lymphoproliferative Disorders. Clin Pediatr Hematol Oncol 2021;28:14-27. [DOI: 10.15264/cpho.2021.28.1.14] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Torres-Cabala CA, Huen A, Iyer SP, Miranda RN. Gamma/Delta Phenotype in Primary Cutaneous T-cell Lymphomas and Lymphoid Proliferations: Challenges for Diagnosis and Classification. Surg Pathol Clin 2021;14:177-94. [PMID: 34023099 DOI: 10.1016/j.path.2021.03.001] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
10 Han B, Hur K, Ohn J, Kim TM, Jeon YK, Kim YC, Mun JH. Hydroa vacciniforme-like lymphoproliferative disorder in Korea. Sci Rep 2020;10:19294. [PMID: 33168864 DOI: 10.1038/s41598-020-76345-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Fujiwara S, Nakamura H. Chronic Active Epstein-Barr Virus Infection: Is It Immunodeficiency, Malignancy, or Both? Cancers (Basel) 2020;12:E3202. [PMID: 33143184 DOI: 10.3390/cancers12113202] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
12 El-Mallawany NK, McClain KL. Checkmate for EBV-HLH. Blood 2020;135:782-4. [PMID: 32163559 DOI: 10.1182/blood.2020005041] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
13 İmren IG, Demirkan N, Çomut E, Duygulu Ş. Epstein-Barr virus-associated hydroa vacciniforme-like lymphoproliferative syndrome: excellent response to antiviral therapy. Int J Dermatol 2020;59:e452-4. [PMID: 32808321 DOI: 10.1111/ijd.15141] [Reference Citation Analysis]
14 Chabay P, Lens D, Hassan R, Rodríguez Pinilla SM, Valvert Gamboa F, Rivera I, Huamán Garaicoa F, Ranuncolo SM, Barrionuevo C, Morales Sánchez A, Scholl V, De Matteo E, Preciado MV, Fuentes-Pananá EM. Lymphotropic Viruses EBV, KSHV and HTLV in Latin America: Epidemiology and Associated Malignancies. A Literature-Based Study by the RIAL-CYTED. Cancers (Basel) 2020;12:E2166. [PMID: 32759793 DOI: 10.3390/cancers12082166] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 4.5] [Reference Citation Analysis]
15 Gupta N, Bagg A. An atypical systemic form of chronic active EBV infection. Leuk Lymphoma 2020;61:3030-2. [PMID: 32643480 DOI: 10.1080/10428194.2020.1789628] [Reference Citation Analysis]
16 Cunningham ET, Zierhut M. Epstein-Barr Virus and the Eye. Ocular Immunology and Inflammation 2020;28:533-7. [DOI: 10.1080/09273948.2020.1760549] [Cited by in Crossref: 2] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
17 Miyake T, Iwatsuki K, Hirai Y, Yamamoto T, Hamada T, Fujii K, Imamura H, Morizane S. The aim of the measurement of Epstein-Barr virus DNA in hydroa vacciniforme and hypersensitivity to mosquito bites. J Med Virol 2020. [PMID: 32255500 DOI: 10.1002/jmv.25811] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]